Berotralstat-d4-1
Berotralstat-d4-1 (BCX7353-d4-1) is the deuterium labeled Berotralstat (HY-109127). Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema.
For research use only. We do not sell to patients.
- Formula: C30H22D4F4N6O
- Molecular Weight:566.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled Cas 1809010-50-1
-
Molecular Weight 566.59
-
Formula C30H22D4F4N6O
-
SMILES
O=C(C1=CC(C(F)(F)F)=NN1C2=CC=CC(CN)=C2)NC3=CC([C@@H](C4=CC=CC(C#N)=C4)NCC5C([2H])([2H])C5([2H])[2H])=CC=C3F
-
Synonyms
BCX7353-d4-1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)